PubMed COVID-19 Clinical Care
47271 - 47280 of 57753 results found
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization
Description
COVID-19 inactivated vaccine-induced humoral responses in patients with lung cancer (LCs) to SARS-CoV-2 wild-type (WT) strain and variants BA.4/5 after the primary 2-dose and booster vaccination remained unknown. We conducted a cross-sectional study
Mucosal immunity in health care workers' respiratory tracts in the post-COVID-19 period
Description
Coronavirus disease (COVID-19) has generated interest in the assessment of systemic immune status, but existing knowledge about mucosal immunity is clearly insufficient to understand the full pathogenetic mechanisms of the disease. The aim of this
Descriptive assessment of COVID-19 responses and lessons learnt in Cambodia, January 2020 to June 2022
Description
As a member state of the International Health Regulations 2005, Cambodia is continuously strengthening its capacity to respond to health emergencies and prevent the international spread of diseases. Despite this, Cambodia's capacity to prevent
Commentary on "Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection"
Description
No abstract
An analysis of suicide rates in Kerman province, the largest province in Iran, before and after COVID-19: (2017-2020)
Description
This study aimed to investigate the suicide incidence rate in Kerman before and after the pandemic and the characteristics of suicides. During four years, 642 suicide occurred in Kerman province. The suicide rate of suicide has increased in 2020
Waning effectiveness against COVID-19-related hospitalisation, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study
Description
CONCLUSIONS: Significant risk reduction against COVID-19-related hospitalisation and mortality after CoronaVac or BNT162b2 vaccination was observed for >240 and >120 days after second and third dose compared to unvaccinated, despite significant
OPTN/SRTR 2021 Annual Data Report: Lung
Description
The number of lung transplants has continued to decline since 2020, a period that coincides with the onset of the COVID-19 pandemic. Lung allocation policy continues to undergo considerable change in preparation for adoption of the Composite
